Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma: A Prospective, Single-arm, Multicenter Study

NCT06168292 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT06168292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06168292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma: A Prospective, Single-arm, Multicenter Study
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2024
Completion date
June 30, 2030
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract carcinoma, radio-frequency ablation, radiotherapy